Pantelidou, C., Cherubini, G., Lemoine, N. R., & Halldén, G. (2016). The E1B19K-deleted oncolytic adenovirus mutant AdΔ19K sensitizes pancreatic cancer cells to drug-induced DNA-damage by down-regulating Claspin and Mre11. Oncotarget.
Citação norma ChicagoPantelidou, Constantia, Gioia Cherubini, Nick R. Lemoine, and Gunnel Halldén. "The E1B19K-deleted Oncolytic Adenovirus Mutant AdΔ19K Sensitizes Pancreatic Cancer Cells to Drug-induced DNA-damage By Down-regulating Claspin and Mre11." Oncotarget 2016.
Citação norma MLAPantelidou, Constantia, Gioia Cherubini, Nick R. Lemoine, and Gunnel Halldén. "The E1B19K-deleted Oncolytic Adenovirus Mutant AdΔ19K Sensitizes Pancreatic Cancer Cells to Drug-induced DNA-damage By Down-regulating Claspin and Mre11." Oncotarget 2016.